Steven Kalkanis, M.D.

Dr. Steven Kalkanis is the Executive Vice President of Henry Ford Health, CEO of Henry Ford Hospital and CEO of the Henry Ford Medical Group.

In January 2020, after an extensive national search, Dr. Kalkanis was named the Chief Executive Officer of the Henry Ford Medical Group, with over 2,000 physicians and researchers, and Chief Academic Officer and Senior Vice President of Henry Ford Health, with over 1,100 ACGME-approved residents and fellows across five acute care hospitals, based in southeast Michigan. He also serves as the dyad leader for Henry Ford Hospital in Detroit as well as the broader clinical delivery system for Henry Ford Health. Before taking over as CEO, Dr. Kalkanis served as professor and chair of the Department of Neurosurgery, and co-director of the Neuroscience Institute at Henry Ford in Detroit, Michigan, where he also served as the founding Medical Director of the Henry Ford Cancer service line, one of the largest in the country, and oversaw the building of the new Brigitte Harris Cancer Pavilion at Henry Ford. Dr. Kalkanis and his team also spearheaded one of the country’s most comprehensive precision medicine and molecular tumor board programs for all cancer types.

In 2021, Dr. Kalkanis was also named the inaugural President of the newly formed Henry Ford Health-Michigan State University Health Sciences enterprise, while serving as the first regional dean of the Henry Ford campus of the MSU College of Human Medicine.

In 2023 Dr. Kalkanis was named CEO of Henry Ford Hospital. It’s the first time in Henry Ford Health’s history that its primary academic and complex care hub and medical group are under singular physician leadership. His expanded role came on the heels of the system and key partners having announced a $2.5 billion investment to reimagine Henry Ford’s academic healthcare campus, including a new hospital facility and patient tower, and its surrounding neighborhood in Detroit.

‍